Dechra Wins FDA Approval for Canine CosACTHen®
OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...
Veterinary Medicine
Advertisement
Gallant Advances Stem Cell Therapy for Canine OA
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
Elanco Secures EUA for Screwworm Treatment in Livestock
INDIANAPOLIS, INDIANA, April 27, 2026 Elanco Animal Health has received Emergency Use Authorization (EUA) from the U.S. Food and...
EMA Recommends First RNA-Based Veterinary Vaccine in EU
AMSTERDAM, Netherlands, April 17, 2026 The European Medicines Agency (EMA), through its Committee for Veterinary Medicinal Products (CVMP), has...
Boehringer Introduces LENZELTA Vaccine for Mastitis Control
INGELHEIM, GERMANY, April 13, 2026 Boehringer Ingelheim has introduced LENZELTA®, a new veterinary vaccine designed to prevent mastitis in...
Advertisements
FDA Authorizes Credelio for New World Screwworm in Dogs
INDIANAPOLIS, Ind., October 24, 2025 — In a landmark decision for veterinary medicine and regulatory preparedness, Elanco Animal Health...
Phibro Animal Health Licenses Novel Periodontal Therapy for Dogs
TEANECK, N.J., October 9, 2025 — Phibro Animal Health Corporation (NASDAQ: PAHC) announced a licensing agreement with Lighthouse Pharmaceuticals,...
Merck Animal Health Showcases BRAVECTO® Injectable Data at WSAVA 2025
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
Gallant Advances First Ready-to-Use Veterinary Stem Cell Therapy
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
Global Veterinary Alliance Strengthens One Health and Education
MANHATTAN, Kan., August 2025 — Kansas State University, Iowa State University, and University College Dublin have announced a landmark...
Advertisement
